News
- The study investigates the anatomical dye distribution patterns and effectiveness of nerve blockade between two catheter placement techniques (parallel vs. perpendicular) for continuous adductor ...
The adductor canal was opened, ... Once the block in the superficial femoral artery has been demonstrated, ... The artery is found adherent to the saphenous nerve and adjacent fat.
In patients who underwent inpatient total knee arthroplasty (TKA), continuous adductor canal block (cACB) resulted in better outcomes and less need for opioids than epidural analgesia, according to ...
Continuous adductor canal block resulted in better outcomes and less need for opioids than epidural analgesia after inpatient total knee arthroplasty. In patients who underwent inpatient total ...
Comparison of genicular nerve block with adductor canal block for postoperative pain management in patients undergoing arthroscopic knee ligament reconstruction: A randomised controlled trial. Indian ...
For patients undergoing ACL reconstruction, a femoral nerve block is associated with lower incidence of excessive opioid consumption than adductor canal block. MONDAY, April 8, 2024 (HealthDay News) - ...
For patients undergoing anterior cruciate ligament (ACL) reconstruction, a femoral nerve block (FNB) is associated with a lower incidence of excessive opioid consumption than adductor canal block ...
EXPAREL (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older, and postsurgical regional analgesia via ...
FDA expands indications for bupivacaine liposome injectable suspension (Exparel; Pacira BioSciences, Inc.) for use in adult patients as an adductor canal block and a sciatic nerve block in the ...
An adductor canal block is used for anesthesia and analgesia for surgery of the knee, medial lower leg, and ankle surgeries. A sciatic nerve block in the popliteal fossa is used for anesthesia and ...
— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results